Press releases

Scholar Rock to Present Data from TOPAZ Ambulatory Cohort Analysis at the 2022 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Read This Press Release

Scholar Rock Reports Full Year 2021 Financial Results and Highlights Business Progress

Read This Press Release

Scholar Rock to Present at Cowen’s 42nd Annual Health Care Conference

Read This Press Release

Scholar Rock to Present Biomarker Strategy for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit

Read This Press Release

Scholar Rock Provides Corporate Update and Highlights Priorities for 2022

Read This Press Release

Scholar Rock to Present at the 40th Annual J.P. Morgan Healthcare Conference

Read This Press Release

Scholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA)

Read This Press Release

Scholar Rock Presents Data from Part A of the DRAGON Phase 1 Trial Evaluating SRK-181 as Monotherapy and in Combination with Anti-PD-(L)1 for the Treatment of Solid Tumors -- Announces Advancement into Part B

Read This Press Release